Last reviewed · How we verify
NCT01580358
Changhua Christian Hospital
NA trial testing Shen-Mai San in Cancer Patients Undergoing Chemotherapy or Radiotherapy in 60 participants. Status unknown.
1 June 2012
Quick facts
| Lead sponsor | Changhua Christian Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 October 2009 |
| Primary completion | 1 June 2012 |
| Estimated completion | 1 September 2012 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Shen-Mai San — full drug profile →
- Starch (STARCH) — full drug profile →
Conditions studied
- Cancer Patients Undergoing Chemotherapy or Radiotherapy — all drugs for Cancer Patients Undergoing Chemotherapy or Radiotherapy →
Sponsor
Changhua Christian Hospital
Who can join
Adults 18 to 90, any sex, with Cancer Patients Undergoing Chemotherapy or Radiotherapy. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change from baseline in EORTC QOL-C30 at four weeks
Time frame: baseline and four weeks
Sponsor's own description
Using Shen-Mai-San for cancer patients undergoing chemotherapy or radiotherapy could help these people improve the quality of life.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity.
Schlaak RA, SenthilKumar G, Boerma M, Bergom C. · · 2020 · cited 42× · PMID 32053873 · DOI 10.3390/cancers12020415 -
Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial.
Lo LC, Chen CY, Chen ST, Chen HC, et al · · 2012 · cited 28× · PMID 23206440 · DOI 10.1186/1745-6215-13-232 -
Radiation-Induced Heart Diseases: Protective Effects of Natural Products.
Musa AE, Shabeeb D. · · 2019 · cited 26× · PMID 31075882 · DOI 10.3390/medicina55050126
Verify or expand the search:
- PubMed search for NCT01580358
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Changhua Christian Hospital trials
Trials by the same sponsor.
- NCT07040215 — Effects on Subacute Stroke With Robotic Assistive Gait Training · NA · recruiting
- NCT06970834 — Explore the Effect of Bitter Melon Peptides on Glycemic Control and Metabolic Indicators in Diabetic Patients · NA · not yet recruiting
- NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
- NCT06334237 — Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine · recruiting
- NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01580358 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changhua Christian Hospital
- Last refreshed: 19 June 2012
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01580358.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing